Aim: To develop Finasteride-loaded self micro-emulsifying drug delivery systems (SMEDDS) for the treatment of hormonal associated problems. Materials & methods: Ternary phase diagrams were constructed to obtain self-emulsification regions. Multivariate statistical methods viz. Principal component analysis and agglomerative hierarchy clustering analysis were used to evaluate the microemulsions stability. In vitro redispersibility study was adopted and two formulations were selected for spray-drying. Further investigations were performed (Fourier transform infrared, x-ray diffraction and transmission electron microscopy). Finally, the in vivo performance was tested in human volunteers. Results: Multivariate statistical methods selected stable SMEDDS. Spray-drying utilizing maltodextrin/leucin carrier system yielded a flowable product. Selected solid SMEDDS scored 129.35% relative bioavailability compared with a commercial tablet. Conclusion: The developed SMEDDS poses successful platform for glucosteroid analogs oral delivery.
Usually the formulation scientists face big challenges in developing successful and effiecient drug delivery systems for drugs exhibiting low bioavailability due to poor solubility such as the drugs belonging to the BCS class II [1] . This strategy of augmenting the effects of conventional drugs and developing new drug products goes side by side with synthesizing new drug molecules. Accordingly, much interest in the recent years has been focused on improving the solubility of poorly water-soluble drugs either by using formulation strategies such as crystal engineering, solid dispersion, cyclodextrin complexation, lipidic systems, micronization, utilizing soft colloidal nanocarriers or chemical strategies such as salt formation and prodrugs [2] .
Finasteride, a 5α-reductase inhibitor, which belongs to BCS class II drugs has been extensively studied and clinically used orally for the treatment of benign prostatic hyperplasia, androgenetic alopecia, seborrhoea and female hirsutism [3] . The mechanism of action of this drug includes the blockage of the conversion of testosterone hormone to the stronger androgenic counterpart namely the dihydrotestosterone [4] . Finasteride, like all glucocorticoid analogs, is a substrate for the efflux transporter P-glycoprotein in the GI tract [5] . Furthermore, Finasteride is liable to CYP3A4 extensive metabolism in the liver [6] . Hence, attempts to enhance its bioavailability are warranted. Enhancement of Finasteride biavailability (63%) [6, 7] like all other BCS class II drugs and especially the low soluble steroids, can be achieved. Nano-based drug delivery vehicles, especially the lipidic carriers, have recently gained wide acceptance for enhancing the bioavailability of poorly soluble drugs. Specifically, self-microemulsifying drug delivery systems (SMEDDS) have emerged as effective delivery systems owing to the numerous merits they offer. The potential advantages of SMEDDS include: first, the capability of SMEDDS in by-passing hepatic portal route and promoting the lymphatic transport of lipophilic drugs, second, SMEDDS components cause the reduction of metabolism by cytochrome-P450 family of enzymes present in the gut enterocytes and liver hepatocytes and finally, the ability of certain SMEDDS formulations to inhibit the P-glycoprotein (P-gp) efflux and hence promoting the drug absorption [8, 9] . Moreover, the easiness of the preparation of these nano-colloidal carriers is considered very tempting.
SMEDDS formulations are mixtures composed of an oil, a surfactant or mixture of surfactants or an additional cosurfactant (or solubilizer), and a drug lacking the aqueous phase needed for emulsification. The basic principle of this system is its ability to form fine oil-inwater (o/w) nanoemulsions under gentle agitation following dilution by aqueous phases. It is then the digestive motility of the stomach and intestine that provide the agitation required for self-emulsification in vivo in the lumen of the gut. This spontaneous formation of an emulsion in the GI tract presents the drug in a solubilized dispersed form, and the small size of the formed droplets provides a large interfacial surface area for drug absorption. Furthermore, the presence of lipid in the formulation helps to improve the bioavailability by affecting the drug absorption. Selection of a suitable self microemulsifying formulation depends upon the evaluation of the solubility of the drug in various components, the area of the self-emulsifying region of the assessed system and the droplet size and stability of the resultant emulsion following self-emulsification [10] .
Although not fully explored in drug delivery, multivariate statisitical methods viz. Principal component analysis (PCA) and agglomerative hierarchical cluster analysis (AHC) were previously adopted to extract successful drug delivery formulations. For example, the use of PCA was utilized to generate a quantita- In another interesting study, Martins et al., 2012, employed PCA followed by partial least squares analysis to assess the qualitative and quantitative effects of different variables such as: lipid and surfactant type and their used concentrations on parameters related to storage stability [14] .
These are considered exploratory analysis techniques, that, depending on the analysis objective, can be used on its own to look for features/patterns/clusters in the data during an investigation or for product and process monitoring or that can be simply used as the starting point of a more complex analysis with the purpose of providing the data analyst an initial overview of the dataset [15] .
Furthermore, preparation of solid SMEDDS is considered a formulation enhancement method to obtain the SMEDDS in a more easily packed and stable dry state. They also overcome the other few limitations of liquid SMEDDS such as: the interaction with capsules shells and the probable precipitation of the incorporated drug due to temperature variations [16] . The use of liquid and solid SMEDDS has been exploited to solve the solubility problems of many drugs. Aside from the solubility issues, the inhibition of P-gp activity is commonly known for the polyethoxylated pharmaceutical excipients, for example, Tween 80 ® and Labrasol ® , that are used in the SMEDDS formulation, while the inhibition of CYP3A4 metabolic enzymes is reported for oils like Capryol 90 ® that was previously successfully formulated in SMEDDS as well [17, 18] .
In light of the above, the work in the current study comprised the development of various novel stable self micro-emulsifying drug delivery systems containing useful ingredients such as the polyethoxylated surfactants and Capryol 90 for Finasteride delivery. Stability evaluation for best formulations selection was carried out based on multivariate statistical methods and solid SMEDDS preparation using spray-drying technique with subsequent characterization of the selected formulations was accomplished. In vitro and in vivo assessments were further performed in order to evaluate the successfulness of the produced formulations. The solubility of Finasteride was determined in various oils, surfactants and cosurfactants, respectively, to identify the most suitable vehicles that possess good solubilizing capacity for the drug. An amount of 0.5 gm of each of the selected vehicles was added to each capped vial containing an excess amount of Finaste- Research Article Fagir, Hathout, Sammour & ElShafeey ride (250 mg). After sealing, the mixture was heated at 40°C in a water bath to facilitate the solubilization. After, the mixtures were shaken at 25°C for 48 h. After reaching equilibrium, each vial was centrifuged at 6000 rpm for 15 min, and the excess insoluble Finasteride was removed by filtration using a membrane filter (0.45 μm, 13 mm, Whatman, USA). The concentration of the soluble Finasteride was determined by HPLC analysis.
Materials & methods

Materials
Detection of Finasteride using HPLC
Quantification of Finasteride was performed using an HPLC system (Agilent, CA, USA) consisting of a pump, an UV detector and a C18 column (Sunfire, [5 μm, 4.6 × 100 mm]). The mobile phase consisted of 0.025 M KH 2 PO 4 pH 3, Acetonitrile, methanol in the volume ratio 40:30:30, respectively. The flow rate of the mobile phase was 1 ml/min at 25 ® C. The injection volume was 50 μl and the column effluent was monitored at a UV length of 237 nm. The method accuracy was 99.99% with an LOQ of 100 ng/ml.
Construction of ternary phase diagrams
According to the solubility study performed, ternary phase diagrams were plotted by selecting highly ME 4 24 h ME 3 24 h ME 6 24 h ME 2 24 h ME 1 24 h ME 5 24 h ME 7 24 h ME 8 24 h ME 4 30 min ME 7 30 min ME 3 30 min ME 2 30 min ME 6 30 min ME 5 30 min ME 1 30 min ME 8 30 min ME 7 24 h ME 4 24 h ME 3 24 h ME 1 24 h ME 2 24 h ME 6 24 h ME 5 24 h ME 4 30 min ME 1 30 min ME 3 30 min ME 2 30 min ME 5 Self-microemulsifying systems of Finasteride Research Article solubilizing ingredients and representing surfactant, cosurfactant and oil on each apex of the triangle. A series of SMEDDS were prepared with varying concentrations of oil (Capryol 90 or Labrafac cc), surfactant (Tween 80) and cosurfactants (Transcutol or Labrasol). For any mixture, the total mass percentages of oil, surfactant and cosurfactant were always adjusted to 100%. One gram mixture was always prepared, to which, 100 ml of bidistilled water was added, followed by gentle agitation. The existence of SMEDDS that could self-emulsify under dilution and gentle agitation to form clear or slightly bluish dispersions was identified. The corresponding zones of SMEDDS formation were represented in a ternary phase diagram.
Preparation of Finasteride SMEDDS
Following the study and comparison of the constructed ternary phase diagrams, some SMEDDS formulations were selected for drug incorporation and further optimization.
Finasteride was dissolved in the oil/surfactant mixture and the dispersion was gently shaken at 25°C for 5 min. The cosurfactant was then added and shaking was proceeded for 30 min. The prepared SMEDDS were stored in tightly sealed glass bottles at room Reconstituted SMEDDS droplet size analysis
The average particle size and size distribution (polydispersity index; PDI) of the reconstituted liquid SMEDDS were analyzed by dynamic light scattering measurements using a Zetasizer Nano ZS (Malvern Instruments, UK). The prepared SMEDDS (1 g) were subjected to measurement following dilution with high-purity de-ionized water (40 ml). Particle size and PDI measurements were performed at a scattering angle of 173°.
Evaluating the reconstituted SMEDDS stability using multivariate statistical methods Two independent multivariate statistical analysis methods namely, the PCA and the agglomerative hierarchy clustering (AHC) were employed using XLSTAT software version 2008.6.03 (Addinsoft, Andernach, Germany). The reconstituted SMEDDS formulations were evaluated on the basis of change in two criteria: the particle size (P.S.) and polydispersity index (PDI) at two time periods: 30 min and 24 h after preparation. For the PCA, the covariance matrices were obtained and two principal components were extracted. The data were normalized with respect to SD prior to analysis [11, 14] . As for AHC, single linkage (nearest neighbour) was used as the clustering method while the Euclidean distance was used for distance measurements between data and schematic dendograms were hence obtained. Formulations with their 30 min and 24 h results clustered together were chosen for further investigations.
In vitro redispersibility study of Finasteride from the selected formulations Development of a LC-MS/MS validated method for the accurate determination of Finasteride A sensitive, selective and accurate LC-MS/MS method was developed and validated for determination of Finasteride. A shimadzu Prominence (Shimadzu, Japan) series LC system equipped with degasser (DGU-20A3), solvent delivery unit (LC-20AB) with an auto-sampler (SIL-20 AC) was used to inject 20 μl aliquots of the processed samples on a Luna C 18 (phenomenex, USA) (50 × 4.6) mm, 5 μm particle size. The Guard column was phenomenex C 18 (5 × 4.0) mm, 5 μm particle size. All analysis was carried out at room temperature.
Sample analysis was performed using isocratic mobile phase consisted of acetonitrile and 0.1% aqueous formic acid (7:3 v/v) at a flow rate of 0.50 m l /min. Quantitation was achieved by MS/MS detection in positive ion mode using a MDS Sciex (CA, USA) API-4000 mass spectrometer, equipped with (ESI), a Turbo ionspray interface at 350°C. The ion spray voltage was set at 5500 V. The common parameters, viz. curtain gas, nebulizer gas, collision gas and auxillary gas were set at 25, 20, 5 and 40 psi, respectively. The compound parameters: declustering potential, collision energy, entrance potential and collision exit potential were 100, 34, 10 and 9 V for finasteride and 20, 28, 10 and future science group 
In vitro evaluation of the selected formulations
In vitro redispersibility of Finasteride from selected stable formulations together with Proscar ® commercial tablets was accomplished using a US Pharmacopeia type II dissolution apparatus rotating at 50 rpm as recommended by the US FDA.
Hard gelatin capsules size '0' filled with Finasteridecontaining different SMEDDS formulations (equivalent to 5 mg drug; 500 μl and 1.02 g for the liquid and solid SMEDDS, respectively) were each placed in 100 ml phosphate buffer pH 6.8 at 37°C with 50 rpm rotating speed. Additionally, Proscar commercial tablets containing 5 mg drug were placed in 900 ml of the same dissolution medium and at the same experimental conditions. Samples (1 ml) were withdrawn at regular time intervals (15, 30, 60, 90 , 120 and 150 min) and filtered using a 0.45 μm filter (Thermo Fisher Scientific, MA, USA). An equal volume of the respective dissolution medium was always added after sampling to compensate for the removed volume. The drug content of the samples was assayed using the aforementioned LC-MS/MS assay method. All measurements were performed in triplicates.
Preparation of spray dried SMEDDS
Selected SMEDDS were chosen for drug incorporation and preparation of dry SMEDDS formulation. An Research Article Fagir, Hathout, Sammour & ElShafeey amount of 5 mg drug was dissolved in 500 μl of selected liquid SMEDDS diluted with 100 ml of distilled water. The diluted SMEDDS were blended with a carrier system (500 mg) composed of maltodextrin and l -leucine mixture (Maltodextrin: l -leucine = 4:1, mass ratio) where the mass ratio SMEDDS: carrier system was 1:1. The suspension was stirred for 15 min at 600 rpm to ensure homogenous dispersion. The resulting mixture was spray dried using Buchi mini spray dryer B-190 apparatus (Buchi, Switzerland) under the following conditions: inlet temperature, 120°C; outlet temperature 60°C; aspiration, 85%; drying air flow, 500 Nl/h and feeding rate of the nanoemulsion, 5 ml/min.
Evaluation of spray dried SMEDDS Determination of process yield
The mass of the spray dried powders was determined gravimetrically and subsequently the process yield was calculated according to the following equation: Process yield% = (recovered mass/mass entered in the spray drier) × 100.
Drug content
The drug content in the spray dried powder was determined using the aforementioned LC-MS/MS method. Briefly, the drug content in 10 mg samples of each formulation was extracted using absolute ethanol and the aliquot was assayed for Finasteride. The determinations were done in triplicate for each formula and the mean value was calculated.
Morphological analysis of solid SMEDDS
The outer macroscopic structures of Finasteride solid SMEDDS formulations were examined using a scanning electron microscope (S-4100, Hitachi, Japan) with an image analysis system (Image Inside, Ver 2.32).
Flowability determination Angle of repose
The fixed height cone method was adopted by measuring the heap of granules formed by passing 10 gm of the sample through a funnel onto a horizontal surface. The angle of repose (θ) was calculated from the equation:
where D is the average diameter of the formed cone and h is the pile height.
Powder density measurements
Ten grams of powder were poured into 25 ml graduated cylinder. The cylinder was gently hit onto a wooden surface three-times from a height of 1 inch at a time interval of 2 s. The bulk density (ρ bulk ) was then obtained by dividing the weight of the sample in grams by the final volume in cm 3 of the sample contained in the cylinder. After, the graduated cylinder was tapped until a constant volume was observed and the volume of the powder was then recorded (true or tapped volume V t ). The tapped density (ρ tap ) was calculated by dividing the weight of the powder under test by V t . Evaluation of the prepared powders was carried out by calculating Hausner ratio (HR) and Carr's Index (CI). HR was calculated according to the following equation:
Usually, HR and the angle of repose are used together to evaluate powder flowability. It also indicates interparticles friction.
CI was also calculated according to the following equation:
The compactability index or CI is indicative of the powder compressibility and stability. HR less than 1.25 and CI between 5 and 18% are usually considered highly accepted [19] .
Fourier transform infrared spectroscopy
The Fourier transform IR (FT-IR) spectra were obtained for spray dried SMEDDS. FT-IR spectra were recorded on a Nicolet 670 FT-IR spectrometer in potassium bromide discs. The dry samples (2-3 mg) were ground with 100 mg of dry potassium bromide powder and compressed into a disc with a hydrostatic press. The scanning range was 400-4000 cm -1 .
X-ray diffraction
In order to determine the physical state of Finasteride in spray dried SMEDDS, x-ray diffraction (XRD) patterns of the prepared samples were recorded on an x-ray diffractometer with area detector operating at a voltage of 40 kV and a current of 30 mA using CuKα radiation (k = 0.154 nm), and x-ray tube PW3373/00CuLFF. The scanning rate was 1.2°/min. The scanning range of 2θ was from 0 0 to 70 0 at room temperature.
Particle size of reconstituted spray dried SMEDDS
The average droplet size and polydispersity index of solid SMEDDS after reconstitution in distilled filtered water were determined by photon correlation spectroscopy as previously mentioned. All measurements were repeated in triplicates and average values were calculated. A total of 100 mg of selected SMEDDS formulation was diluted 1000-times with deionized water. Consequently, percentage transmittance was measured spectrophotometrically at 560 nm using deionized water as a blank [20] .
Transmission electron microscopy
The morphology of the obtained microemulsions after suitable dilution of the selected SMEDDS with water was studied using Jeol TEM (JEM-1230, Japan). A sample drop was placed on a copper grid. The excess was drawn off using a filter paper. Samples were subsequently stained with phosphotungistic acid solution for 30 s [21] .
In vivo testing of the selected Finasteride formulations Study design & subjects
Six healthy adult male volunteers were participated in this comparative study in a single-dose, two-period randomized cross-over design under fasting condition. The volunteers mean age was 24.8 ± 3.2 years, mean body weight 75.8 ± 8.7 kg and mean height 175.67 ± 7.5 cm. The volunteers had given their written consent after the purpose of the study was fully explained. The study was performed according to the revised Declaration of Helsinki for biomedical research involving human as well as the rules of Good Clinical Practices (GCP) [22, 23] . The study protocol was reviewed and approved by the institutional review board of Genuine Research Center, Cairo, Egypt.
The volunteers were hospitalized at 10:00 p.m. and had a standard dinner in the clinical site. After an overnight fast (10 h), subjects were given a single oral dose from either the commercial product (Proscar) or the formulation LTL2 that was prefilled in 2 capsules size '0' (1.02 g LTL2 solid SMEDDS) according to the randomization plan. Approximately, 6 ml blood samples for Finasteride analysis were drawn into evacuated heparinized glass tubes through an indwelling cannula at 0.00, 0.33, 0.66, 1.00, 1.33, 1.66, 2.00, 3.00, 4.00, 5.00, 6.00, 8.00, 12.00, 24.00 and 48.00 h after dosing. Blood samples were centrifuged at 4000 rpm for 15 min at 4°C; plasma was transferred directly into 5 ml plastic tubes and stored frozen at -70°C pending drug analysis. After a washing out period of 7 days, the study was repeated twice adopting the same procedure to complete the crossover design.
Sample preparation & analysis
A plasma sample 500 μl was transferred to a 10 ml glass test tube, then 50 μl of an internal standard (Torsemide) working solution (1.0 μg/ml) was added. After vortex mixing for 10 s, 4 ml aliquot of ethyl acetate was added using Dispensette Organic (Brand GmbH, Postfach, Germany). The sample was vortex-mixed for 3 min. The organic layer (3 ml) was transferred to a clean glass tube and evaporated to dryness using centrifugal vacuum concentrator Vacufuge 5301 (Eppendorf, Germany) at 40°C. Dry residues were then dissolved in 200 μl of mobile phase and vortexed for 1 min to reconstitute residues, and 20 μl was injected using the autosampler. The samples were analyzed according to the validated LC-MS/MS method explained in section 'Development of a LC-MS/MS validated method for theaccurate determination of Finasteride'.
Pharmacokinetic & statistical analysis
Plasma concentration-time data of Finasteride were analyzed for each subject by noncompartmental pharmacokinetic models using Kinetica ® software version 5 (Thermo Fisher Scientific Inc., MA, USA). The peak plasma concentrations (C max ) and the time of their occurrence (T max ) were directly obtained from the concentration-time data. The area under the plasma concentration-time curve (AUC) from time zero to last measured concentration (AUC 0-t ) was calculated according to the linear trapezoidal rule. Subsequently, the mean residence time (MRT) was obtained. The terminal elimination rate constant (λ z ) was calculated from the terminal portion of the ln (concentration)-time curve using linear regression and subsequently the elimination half life was calculated. Finally, the relative bioavailability of LTL2 formulation with respect to Finasteride commercial tablets was computed.
Results & discussion
Selection of ingredients used for ternary phase diagram construction
The selection of the oils, surfactants and cosurfactants used for SMEDDS formation was based on solubility measurements as shown in Figure 1A . Among the studied oils, maximum solubility of Finasteride was obtained in Capryol 90 and Labrafac cc. Generally, nonionic surfactants were screened for Finasteride solubilization as they possess low toxicities [24, 25] and are considered acceptable for oral ingestion [26, 27] . Tween 80 far preceded all the used surfactants and cosurfactants followed by Transcutol. Accordingly, Tween 80 was chosen as the main surfactant for SMEDDS preparation. Two phase diagrams were constructed: one comprised Capryol 90, Tween 80 and Transcutol while the other was composed of Labrafac cc, Tween 80 and Labrasol. It is worth to mention that Labrasol was utilized as cosurfactant in the second phase diagram due to the high compatability between Tween 80 and Labrasol as reported in literature [28, 29] . The two constructed ternary phase diagrams produced reasonable monophasic zones with water as depicted in Figure 1B . provide a large interfacial surface area and promote the absorption and lymphatic transport of drugs [30] . The relatively high recorded polydispersity indices (>0.2) are considered normal for microemulsions. This is because the interfacial tension of the surfactant monolayer is very low for microemulsion systems and so there is less of a penalty (more chance) for having a non-spherical shape in contrast to the normal emulsions which usually possess spherical structures due to high interfacial tensions favouring the reduction of the globules interfacial areas Self-microemulsifying systems of Finasteride Research Article (The sphere has the lowest interfacial area for a given volume) [31] . They may possess spherical, worm-like or irregular shapes as they form due to reduction in interfacial tensions to very low levels even approaching zero in some cases. Moreover, Table 1 shows the change in particle size and polydispersity indices after 24 h from preparation as compared with the freshly prepared values (30 min after preparation) for the microemulsions formed from the SMEDDS systems Capryol 90/Tween 80/Transcutol and Labrafac cc/Tween 80/Labrasol, respectively. It is also clear that some formulations exhibited changes in particles size, some in polydispersity indices and others in both. It should be also stated that a small particle size for a freshly prepared microemulsions is not usually favourable as smaller diameter particles have high surface energy leading to more collisions and aggregations by time. Accordingly, multivariate statistical methods such as: AHC and PCA were adopted in order to select stable microemulsion formulations based on the analysis of the two criteria together. AHC which is a form of clustering analysis [13] organizes the data according to the similarity between the points (Formulations) in the form of a tree-like diagram (Figure 2A ). On the other hand, PCA usually discriminates between data according to more than criteria by projecting it into new dimensions (vectors) each of them carry contributions from all the initial variables [11] . Usually similar formulations are located close in position to each other [12] . Consequently, for the system Capryol 90/Tween 80/Transcutol, the following pairs were clustered in the same group: ME4 30 min and ME4 24 h and ME5 30 min and ME5 24 h as revealed in the relevant bi-plot (Figure 2Bi) . PCA positioned the same pairs very close to each other according to two main extracted principal components: one accounting for data variability of 56.3% while the other accounting for 43.7%. Nevertheless, pairs (at 30 min and 24 h) of microemulsions 2, 4 and 6 in the system Labrafac cc/ Tween 80/Labrasol were clustered together as depicted by the bi-plot in Figure 2Bii indicating their superior stability and the results were confirmed by PCA where these pairs were positioned in the same groups. To this end, the aforementioned five stability proven microemulsions formulations were selected for subsequent studies.
Redispersibility results Figure 3 displays the redispersibility and dissolution profiles of Finasteride from the selected SMEDDS and Proscar commercial tablets, respectively. For the system Capryol 90/Tween 80/Transcutol, formulation 5 (CTT5) reached almost 60% of redispersed drug after 15 min with a plateau profile afterward. Very poor redispersibility was observed with formulation 4 (CTT4) where less than 5% was reached in 15 min and 40% in 30 min. Better results were achieved using the second system; Labrafac cc/Tween 80/Labrasol where more than 95 and 85% redispersibility were achieved using formulations 4 (LTL4) and 5 (LTL5), respectively, in 30 min. This may be attributed to the smaller particle size recorded for the microemulsions obtained from these formulations compared with those obtained from the first system. In another encounter, formulation 2 (LTL2) scored approximately 60% of redis- Research Article Fagir, Hathout, Sammour & ElShafeey persed drug in 15 min but displaying a plateau profile throughout the time of the experiment. The obtained redispersibility profile was similar to that observed for CTT5. Accordingly, liquid SMEDDS formulations CTT5 and LTL2 were chosen to study the effect of spray drying to obtain carrier-loaded solid formulations on enhancing the redispersility of SMEDDS and hence their subsequent biological performance. It is worth noting that the term 'redispersibility' was used in this section rather than the term 'dissolution' because the adopted evaluations were based on the quantification of total Finasteride after SMEDDS reconstitution whether in a free state or associated with the formed microemulsion [32, 33] . It is obvious from Figure 3 that the redispersibility of Finasteride increased from solid SMEDDS compared with their liquid counterparts reaching approximately 90% redispersion after 150 min which is comparable to the values obtained from Proscar commercial tablets depicted in the same figure. This can be ascribed to better dispersion and reduced agglomeration tendency of the nano-droplets after the carrier dissolution.
Characterization of the spray-dried solid SMEDDS Process yield & drug content Table 2 shows the process yield of masses for the prepared solid SMEDDS where the yield for CTT5 and LTL2 was 70.22 ± 4.12 and 63.58 ± 6.22, respectively. This relatively low yield may be attributed to the use of a lab-scale spray dryer, which usually produces lower yields compared with production scale spray dryers due to higher wall deposits, since air residence times and radial distances from the atomiser to the drying chamber wall are shorter [34] . High values of drug content were obtained after spray drying of the two SMEDDS formulations as shown in Table 2 as well. These high values were also previously obtained in several studies [35, 36] .
Morphological analysis using scanning electron microscopy
Scanning electron microscopicy photos of CTT5 and LTL2 solid SMEDDS are demonstrated in Figure 4Ai & ii, respectively. The spherical morphology was very obvious in the photos inferring the success-future science group Self-microemulsifying systems of Finasteride Research Article fulness of maltodextrin/ l -leucine as a carrier system for spray drying. Maltodextrin was previously proven to be easily spray-dryable with deep and abundant dents available for liquid SMEDDS accommodation with limited tendency for agglomeration into nonspherical lumps [37] . Moreover, l -leucine was previously proven to enhance the flowability of powder blends of drugs such as: Budenoside [38] . Mixing drugs with blends of large particulate carriers is a common practice to enhance flowability especially for industrial and scaling-up purposes [39, 40] .
Flow properties of the prepared SMEDDS
The prepared spray dried formulations (CTT5 and LTL2 solid SMEDDS) possessed free flowing powder properties according to Carr's classification of powder flowability based on angle of repose [41] . These results contradicted the obtained Hausner's ratio calculations (1.59 and 1.61 for CTT5 and LTL2 solid SMEDDS, respectively) which indicated poor flow (>1.25) [42] . The results for CI conformed to these results as the powders scored 33.44 and 36.57% for CTT5 and LTL2, respectively. However, the angle of repose measurements encompass several flow contributing factors and are usually more reliable [41] . CI and HR are empirical methods. And while CI is mainly a measure of powder bridge strength and stability, the HR (HR) is considered with the interparticulate friction solely [43] .
Fourier transformed infrared spectroscopy of the prepared SMEDDS , 2843-2970 cm -1 and 3240 cm -1 corresponding to the vibrational stretchings associated with C=O, C=C, asymmetric and symmetric C-H and N-H, respectively. All these peaks were displayed in the CTT5 and LTL2 solid SMEDDS as obvious in Figure 5B & C, respectively, with broadening and minor shifts in the peaks positions. This indicates physical interaction between the drug and its carrier or with the SMEDDS components which can be attributed to hydrogen bonds formation [44] .
X-ray diffraction Figure 6 demonstrates the x-ray diffraction pattern of Finasteride and the two spray-dried SMEDDS formulations (CTT5 and LTL2). The crystalline physical state of pure Finasteride could be easily inferred from the figure from the sharp peaks at different diffraction angles. Nevertheless, diffraction patterns of spray-dried SMEDDS lacked these sharp peaks indicating sharp decrease in crystallinity. This was always associated with the spray drying process [29, 35] . The amorphous state of poorly water-soluble drugs such as Finasteride in the final solid-SMEDDS formulation is favourable as this form is expected to possess higher internal energy and molecular motion with greater thermodynamic activity compared with its crystalline state which might increase the aqueous solubility and bioavailability of the drug from solid SMEDDS [45] .
Transmission electron microscopy
The morphology of the two investigated SMEDDS formulations after redispersion in water was observed using TEM. The photographs depicted in Figure 4B confirmed the formation of the reconstituted microemulsions after water addition and revealed that the particles after dilution possessed mainly a spheroid shape with few particles exhibiting worm-like or irregular shapes. No signs of coalescence were observed indicating thereby the physical stability of the formulations [46] . Maltodextrin was previously proven to give homogenized and stable reconstituted emulsions upon addition of water to their dried form [47] . It is worth mentioning that TEM photographing of microemulsions is usually a hard task because of the drying step necessary for TEM imaging that might lead to the loss of microemulsion droplets integrity and presence of artifacts [48] .
Pharmacokinetics study in healthy human volunteers
All volunteers fully completed the study. There were no serious adverse events. All adverse events related to the study drug were mild-to-moderate in severity and characteristic of the drug class. Reported adverse events included headache, tachycardia and flushing. The LC-MS/MS assay had a good linearity from 0.1 to 100.0 ng/ml with acceptable within-and between-day reproducibility. The lower limit of finasteride quantification in plasma was 0.1 ng/ml. The intraday accuracy of the method ranged from 92.4 to 105.0% (data not shown) while the intraday precision calculated as CV% ranged from 5.2 to 12.4%. The interday accuracy ranged from 93.2 to 103.1%, while the interday precision ranged from 6.1 to 10.7%. The accuracy of freeze and thaw stability ranged from 88.6% to 98.7%, while its precision ranged from 5.8% to 9.7%. The results of the calculated pharmacokinetic parameters are shown in These results together with the redispersibility and dissolution counterparts support the role of the SMEDDS components in enhancing Finasteride bioavailability. Increasing the bioavailability is usually translated to better therapeutic response with faster treatment outcomes. The lower bioavailability of Finasteride from the commercial product despite its excellent dissolution profile may be attributed to the effect of P-gp efflux pumps on its transport. Therefore, the enhanced bioavailability from SMEDDS formulations (Figure 7) can be ascribed to the combined effects of good solubilisation of the drug, possible absorption through the lymphatic system avoiding liver metabolism and inhibition of P-gp efflux pumps with the SMEDDS formulation components: Tween 80 and Labrasol [18] .
Conclusion
Multivariate statistical methods were utilized in selecting successful Finasteride self micro-emulsifying delivery systems that were further enhanced from the formulation point of view through solid SMEDDS preparation by spray drying. A selected fully characterized formulation scored better pharmacokinetic parameters and better bioavailability compared with a commercial product when tested on human volunteers. In conclusion, all the results demonstrated the enhanced oral delivery of Finasteride using the studied delivery system.
Future perspective
SMEDDS have gained the interest of nanomedicine researchers through the recent years. They contributed in enhancing the oral delivery of several poorly water soluble drugs. Yet, these formulations suffer from many stability problems due to their liquid nature. We speculate more research focus on utilizing advanced multivariate statistical techniques aiding in selecting promising formulations possessing good stability problems. Developing solid SMEDDS utilizing new carrier systems having good flow properties would be the key in delivering these break-through oral delivery systems to the market.
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future science group • Particle size and polydispersity indices (PDI) were measured for the prepared formulations.
The use of multivariate statistical methods in selecting SMEDDS formulations that will lead to stable microemulsion formulations for further investigations
• Agglomerative hierarchical clustering and principal component analysis were utilized in selecting best SMEDDS candidates based on particle size and polydispersity index measurements.
• In vitro redispersibility study was performed for the selected SMEDDS where two formulations (one from each system) were chosen for further enhancement.
Development of solid SMEDDS based on a carrier system composed of maltodextrin/leucine mixture
• Better redispersibility results were obtained for the solid SMEDDS compared with the liquid ones.
• Good flow properties were obtained for the prepared solid SMEDDS.
• Scanning electron microscopy revealed the success of spray-drying in producing spherical solid SMEDDS.
• Characterization of the reconstituted solid SMEDDS was carried out using transmission electron microscopy, particle size and transmittance measurements.
• FTIR analysis confirmed the association of the drug with the carrier and/or SMEDDS components.
• X-ray diffraction patterns demonstrated the amorphous form of the drug in SMEDDS which enhances its solubility and redispersibility.
In vivo study on human volunteers has proven the superiority of the developed solid SMEDDS over a commercial tablet product where129.35% relative bioavailability was scored
• Longer t-half and mean residence time was recorded for the developed solid SMEDDS.
